Further studies on the structural requirements for mast cell degranulating (MCD) peptide-mediated histamine release

Angeliki Buku, Joseph Price

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Mast cell degranulating (MCD) peptide was modified in its two disulfide bridges and in the two arginine residues in order to measure the ability of these analogs to induce histamine release from mast cells in vitro. Analogs prepared were [Ala(3,15)]MCD, [Ala(5,19)]MCD, [Orn(16)]MCD, and [Orn(7,16)]MCD. Their histamine-releasing activity was determined spectrofluorometrically with peritoneal mast cells. The monocyclic analogs in which the cysteine residues were replaced pairwise with alanine residues showed three-to ten-fold diminished histamine-releasing activity respectively, compared with the parent MCD peptide. Substantial increases in activity were observed where arginine residues were replaced by ornithines. The ornithine-mono substituted analog showed an almost six-fold increase and the ornithine-doubly substituted analog three-fold increase in histamine-releasing activity compared with the parent MCD peptide. The structural changes associated with these activities were followed by circular dichroism (CD) spectroscopy. Changes in the shape and ellipticity of the CD spectra reflected a role for the disulfide bonds and the two arginine residues in the overall conformation and biological activity of the molecule.

Original languageEnglish
Pages (from-to)1987-1991
Number of pages5
JournalPeptides
Volume22
Issue number12
DOIs
StatePublished - 1 Jan 2001

Fingerprint

Histamine Release
Mast Cells
Histamine
Arginine
Ornithine
Disulfides
Circular Dichroism
Circular dichroism spectroscopy
Dichroism
Bioactivity
Alanine
Cysteine
Conformations
Molecules
mast cell degranulating peptide
Spectrum Analysis

Cite this

@article{42fd46fc6f4b4c63a6e5846cf1bdf168,
title = "Further studies on the structural requirements for mast cell degranulating (MCD) peptide-mediated histamine release",
abstract = "Mast cell degranulating (MCD) peptide was modified in its two disulfide bridges and in the two arginine residues in order to measure the ability of these analogs to induce histamine release from mast cells in vitro. Analogs prepared were [Ala(3,15)]MCD, [Ala(5,19)]MCD, [Orn(16)]MCD, and [Orn(7,16)]MCD. Their histamine-releasing activity was determined spectrofluorometrically with peritoneal mast cells. The monocyclic analogs in which the cysteine residues were replaced pairwise with alanine residues showed three-to ten-fold diminished histamine-releasing activity respectively, compared with the parent MCD peptide. Substantial increases in activity were observed where arginine residues were replaced by ornithines. The ornithine-mono substituted analog showed an almost six-fold increase and the ornithine-doubly substituted analog three-fold increase in histamine-releasing activity compared with the parent MCD peptide. The structural changes associated with these activities were followed by circular dichroism (CD) spectroscopy. Changes in the shape and ellipticity of the CD spectra reflected a role for the disulfide bonds and the two arginine residues in the overall conformation and biological activity of the molecule.",
author = "Angeliki Buku and Joseph Price",
year = "2001",
month = "1",
day = "1",
doi = "10.1016/S0196-9781(01)00538-1",
language = "English",
volume = "22",
pages = "1987--1991",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "12",

}

Further studies on the structural requirements for mast cell degranulating (MCD) peptide-mediated histamine release. / Buku, Angeliki; Price, Joseph.

In: Peptides, Vol. 22, No. 12, 01.01.2001, p. 1987-1991.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Further studies on the structural requirements for mast cell degranulating (MCD) peptide-mediated histamine release

AU - Buku, Angeliki

AU - Price, Joseph

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Mast cell degranulating (MCD) peptide was modified in its two disulfide bridges and in the two arginine residues in order to measure the ability of these analogs to induce histamine release from mast cells in vitro. Analogs prepared were [Ala(3,15)]MCD, [Ala(5,19)]MCD, [Orn(16)]MCD, and [Orn(7,16)]MCD. Their histamine-releasing activity was determined spectrofluorometrically with peritoneal mast cells. The monocyclic analogs in which the cysteine residues were replaced pairwise with alanine residues showed three-to ten-fold diminished histamine-releasing activity respectively, compared with the parent MCD peptide. Substantial increases in activity were observed where arginine residues were replaced by ornithines. The ornithine-mono substituted analog showed an almost six-fold increase and the ornithine-doubly substituted analog three-fold increase in histamine-releasing activity compared with the parent MCD peptide. The structural changes associated with these activities were followed by circular dichroism (CD) spectroscopy. Changes in the shape and ellipticity of the CD spectra reflected a role for the disulfide bonds and the two arginine residues in the overall conformation and biological activity of the molecule.

AB - Mast cell degranulating (MCD) peptide was modified in its two disulfide bridges and in the two arginine residues in order to measure the ability of these analogs to induce histamine release from mast cells in vitro. Analogs prepared were [Ala(3,15)]MCD, [Ala(5,19)]MCD, [Orn(16)]MCD, and [Orn(7,16)]MCD. Their histamine-releasing activity was determined spectrofluorometrically with peritoneal mast cells. The monocyclic analogs in which the cysteine residues were replaced pairwise with alanine residues showed three-to ten-fold diminished histamine-releasing activity respectively, compared with the parent MCD peptide. Substantial increases in activity were observed where arginine residues were replaced by ornithines. The ornithine-mono substituted analog showed an almost six-fold increase and the ornithine-doubly substituted analog three-fold increase in histamine-releasing activity compared with the parent MCD peptide. The structural changes associated with these activities were followed by circular dichroism (CD) spectroscopy. Changes in the shape and ellipticity of the CD spectra reflected a role for the disulfide bonds and the two arginine residues in the overall conformation and biological activity of the molecule.

UR - http://www.scopus.com/inward/record.url?scp=0035751789&partnerID=8YFLogxK

U2 - 10.1016/S0196-9781(01)00538-1

DO - 10.1016/S0196-9781(01)00538-1

M3 - Article

C2 - 11786181

AN - SCOPUS:0035751789

VL - 22

SP - 1987

EP - 1991

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 12

ER -